This is general education for owners, not medical or legal advice. Clinical protocols must come from current training and your medical director; risk-management specifics from your counsel and carrier.
Stock it like you mean it
The common failure isn't having zero hyaluronidase — it's having a token amount that's adequate for a leisurely cosmetic dissolve and nowhere near enough for an actual occlusion. Managing occlusion can require substantially more product, sometimes across repeated rounds, on a clock measured in minutes to hours. A practice that keeps a single vial "just in case" can run dry in the middle of the one emergency it exists to handle.
Treat quantity as part of the protocol: enough on hand to begin and sustain management, plus a known resupply path. The carrying cost is trivial. The cost of running out mid-emergency is unbounded.
Build the protocol before you need it
An emergency is the worst possible time to figure out your process. Every room that injects filler should operate against a written vascular-occlusion protocol — the recognition signs, the immediate steps, the dosing and reconstitution specifics from current training, the warm-compress and adjunct measures, and the escalation and transfer plan if the situation exceeds what the practice can manage. The clinical content belongs to your medical director and your training; the existence and accessibility of the protocol belongs to the owner.
Pair the protocol with the physical kit — hyaluronidase in adequate quantity, the supplies to reconstitute and inject promptly, and the escalation contacts — kept somewhere every injector can reach in seconds, not a locked cabinet someone has to hunt for keys to open.
Rehearse it
A protocol nobody has practiced is a document, not a capability. The practices that handle occlusion well are the ones where every injector has walked through the steps, knows where the kit is, and doesn't have to think about the sequence under stress. Periodic drills — even brief tabletop walkthroughs — convert a binder into a reflex. The first time your team runs the protocol should not be on a real patient who is actively blanching.
Why this is also a liability moment
An adverse event is going to be judged, fairly or not, on how you responded. An occlusion managed with a documented protocol, adequate product, immediate appropriate intervention, and clear charting looks like a practice meeting the standard of care. The same event in a practice that was unprepared, under-stocked, and improvising looks like negligence — and that difference is what a plaintiff's attorney builds a case on. Preparedness protects the patient first; it protects the practice second, and the order matters.
What to do
- Stock hyaluronidase in genuine occlusion-management quantity, not a token amount, with a known resupply path.
- Adopt a written occlusion protocol authored with your medical director and current training, kept instantly accessible in every injecting room.
- Assemble a physical emergency kit with the product, supplies, and escalation contacts in one grab-and-go place.
- Drill it. Walk every injector through recognition and response on a schedule, so the protocol is muscle memory before it's ever a real patient.
- Document everything about your readiness and any event — preparedness and charting are what separate a managed complication from an indefensible one.
The discipline here is paying for something that, if you do everything right, you hope never earns its keep. That's exactly the point. The kit in the fridge is not an expense; it's the price of being allowed to inject filler at all — and the practices that resent it are the ones who haven't yet had the day that justifies it.
